SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Highlights Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-16			5-day change	1st Jan Change
17.55 ^CNY	-0.96%		-2.01%	+2.81%

01-07	Chinese Drug Regulator Accepts Yiling Pharmaceutical's Application for Qilong Dingchuan Tablets	MT
01-07	Yiling Pharmaceutical Unit Gets Nod to Market Dapagliflozin	MT

Highlights

01-07	Chinese Drug Regulator Accepts Yiling Pharmaceutical's Application for Qilong Dingchuan Tablets	MT
01-07	Yiling Pharmaceutical Unit Gets Nod to Market Dapagliflozin	MT
01-07	Yiling Pharmaceutical Unit Gets Registration Certificate for Herpes Drug	MT
12-07	Yiling Pharmaceutical's Qifang Bitong Tablets Placed in China's Insurance Drug List	MT
11-28	Yiling Pharmaceutical Withdraws Drug Registration Application for Chaihuang Lidan Capsules	MT
11-13	Yiling Pharmaceutical Unit Gets China Nod for Alzheimer's Drug Raw Material	MT
25-10-27	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-27	Yiling pharmaceutical Q3 net profit up 1264.6% Y/Y	RE
25-09-16	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Interim Cash Dividend on A Shares for 2025, Payable on 22 October 2025	CI
25-08-28	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for the First Half of 2025	CI
25-08-27	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-27	Shijiazhuang Yiling Pharmaceutical H1 net profit up 26.0% Y/Y	RE
25-07-11	Yiling Pharmaceutical Receives Regulatory Greenlight for Review of Banxia Baizhu Tianma Granules	MT
25-07-08	Yiling Pharmaceutical Gets Nod to Trial G201-Na Capsule	MT
25-04-28	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-01-22	Yiling Pharmaceutical's Unit Gets Registration Certificate for Qifangbitong Tablets	MT
25-01-08	Yiling Pharma Withdraws Plans to Trial Assisted Reproductive Drug	MT
24-12-02	Yiling Pharmaceutical Unit Gets Nod to Market Simvastatin Tablets in US	MT
24-11-29	Shijiazhuang Yiling Pharmaceutical's Tongluo Mingmu Capsules Added to National Medical Insurance Catalog	MT
24-10-28	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-08-27	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-07-12	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Implements Cash Dividend for the Year 2023, Payable on 19 July 2024	CI
24-05-22	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Cash Dividend Per 10 Shares for 2023	CI
24-04-26	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-26	Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Pharmaceuticals

Highlights

Filters